Reflecting on ISCT 2026 Dublin - A Milestone Moment for ACTRIS
Topics
Events
20 May 2026
ACTRIS made its first international exhibition appearance at ISCT 2026 in Dublin, engaging global stakeholders, exploring collaborations, and gaining insights into the latest developments shaping the cell and gene therapy landscape.
ACTRIS has recently participated as an exhibitor at the ISCT 2026, held from 6 – 8 May 2026 at the Convention Centre Dublin, Ireland — marking our first overseas exhibition on the global stage!
Over the three days, our team had the privilege of engaging with a wide spectrum of global partners and thought leaders — exploring potential collaborations, exchanging ideas and presenting what ACTRIS, as Singapore's national cell therapy facility, has to offer.
Beyond the exhibition floor, our staff also attended several of the conference's scientific sessions. The programme featured in-depth discussions across key themes, including challenges in CGT translation and GMP transition, scaling of workflows, developments in viral vector delivery systems, the integration of AI and automation in bioprocessing and smart manufacturing, as well as regulatory harmonisation and market access strategies.
These conversations reinforced what we already believe: that the field is at an exciting inflection point, and that collaboration across borders is essential to accelerating patient access to life-changing therapies.
As ACTRIS continues to grow and deepen its contributions to the global CGT ecosystem, events like ISCT serve as an important reminder of why we do what we do — and of the remarkable community that is driving this field forward together.
We look forward to the connections made in Dublin and to the conversations that lie ahead. If you would like to learn more about ACTRIS and how we can work together, please feel free to reach out to us.
